EMA issues guidance on choosing most appropriate pediatric drug formulations
This article was originally published in SRA
Executive Summary
The European Medicines Agency has issued a new guideline intended to help drug manufacturers produce pediatric formulations that are most appropriate for use in children in the target age group1.